Tsubaki, M., Komai, M., Itoh, T., Imano, M., Sakamoto, K., Shimaoka, H., . . . Nishida, S. (2014). Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation. BioMed Central.
Chicago Style CitationTsubaki, Masanobu, et al. Nitrogen-containing Bisphosphonates Inhibit RANKL- and M-CSF-induced Osteoclast Formation Through the Inhibition of ERK1/2 and Akt Activation. BioMed Central, 2014.
Cita MLATsubaki, Masanobu, et al. Nitrogen-containing Bisphosphonates Inhibit RANKL- and M-CSF-induced Osteoclast Formation Through the Inhibition of ERK1/2 and Akt Activation. BioMed Central, 2014.
Atenció: Aquestes cites poden no estar 100% correctes.